- Home
- CNMD vs PRCT Comparison
CNMD vs PRCT Comparison
Compare CNMD & PRCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CNMD | PRCT |
|---|---|---|
| Founded | 1970 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Medical Specialities |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.3B |
| IPO Year | 1995 | 2021 |
Fundamental Metrics
Financial Performance| Metric | CNMD | PRCT |
|---|---|---|
| Price | $39.96 | $25.59 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 6 | 11 |
| Target Price | ★ $48.00 | $35.44 |
| AVG Volume (30 Days) | 356.4K | ★ 1.2M |
| Earning Date | 04-29-2026 | 04-29-2026 |
| Dividend Yield | ★ 1.02% | N/A |
| EPS Growth | N/A | ★ 1.71 |
| EPS | ★ 1.51 | N/A |
| Revenue | ★ $1,374,724,000.00 | $308,054,000.00 |
| Revenue This Year | $0.82 | $31.34 |
| Revenue Next Year | $5.48 | $24.52 |
| P/E Ratio | $25.89 | ★ N/A |
| Revenue Growth | 5.18 | ★ 37.22 |
| 52 Week Low | $33.21 | $19.35 |
| 52 Week High | $60.80 | $64.89 |
Technical Indicators
Market Signals| Indicator | CNMD | PRCT |
|---|---|---|
| Relative Strength Index (RSI) | 58.75 | 53.28 |
| Support Level | $39.36 | $22.81 |
| Resistance Level | $46.08 | $27.08 |
| Average True Range (ATR) | 1.46 | 1.21 |
| MACD | 0.65 | 0.25 |
| Stochastic Oscillator | 93.47 | 83.94 |
Price Performance
Historical ComparisonAbout CNMD CONMED Corporation
Conmed Corp is a medical technology company that provides devices and equipment for surgical procedures. The company's products are used by surgeons and other healthcare professionals across specialties, including orthopedics, general surgery, gynecology, thoracic surgery, and gastroenterology. Geographically, the company operates in the United States, Europe, the Middle East & Africa, Asia Pacific, and the Americas, excluding the United States. The majority of revenue is generated from the United States.
About PRCT PROCEPT BioRobotics Corporation
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. The company develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.